- Home
- KVAC vs SGMO Comparison
KVAC vs SGMO Comparison
Compare KVAC & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KVAC
- SGMO
- Stock Information
- Founded
- KVAC 2021
- SGMO 1995
- Country
- KVAC United States
- SGMO United States
- Employees
- KVAC N/A
- SGMO N/A
- Industry
- KVAC
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KVAC
- SGMO Health Care
- Exchange
- KVAC Nasdaq
- SGMO Nasdaq
- Market Cap
- KVAC 210.5M
- SGMO 180.5M
- IPO Year
- KVAC 2023
- SGMO 2000
- Fundamental
- Price
- KVAC $10.87
- SGMO $2.05
- Analyst Decision
- KVAC
- SGMO Buy
- Analyst Count
- KVAC 0
- SGMO 3
- Target Price
- KVAC N/A
- SGMO $7.00
- AVG Volume (30 Days)
- KVAC 38.7K
- SGMO 15.7M
- Earning Date
- KVAC 01-01-0001
- SGMO 11-12-2024
- Dividend Yield
- KVAC N/A
- SGMO N/A
- EPS Growth
- KVAC N/A
- SGMO N/A
- EPS
- KVAC 0.43
- SGMO N/A
- Revenue
- KVAC N/A
- SGMO $52,291,000.00
- Revenue This Year
- KVAC N/A
- SGMO N/A
- Revenue Next Year
- KVAC N/A
- SGMO $71.79
- P/E Ratio
- KVAC $25.20
- SGMO N/A
- Revenue Growth
- KVAC N/A
- SGMO N/A
- 52 Week Low
- KVAC $10.28
- SGMO $0.30
- 52 Week High
- KVAC $10.91
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- KVAC 68.42
- SGMO 54.17
- Support Level
- KVAC $10.81
- SGMO $1.72
- Resistance Level
- KVAC $10.88
- SGMO $3.18
- Average True Range (ATR)
- KVAC 0.02
- SGMO 0.39
- MACD
- KVAC 0.00
- SGMO -0.03
- Stochastic Oscillator
- KVAC 71.43
- SGMO 24.67
About KVAC Keen Vision Acquisition Corporation
Keen Vision Acquisition Corp is a blank check company.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.